Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease - Sato, S; Kuwana, M; Fujita, T (Mod Rheumatol, 2013)
et al.